Absolutely Strauss..this company and its shareholders have a genuine shot at the title here ...
The new board is proposing to step up into the ring and have a few swings.....they have a proven track record as you say with DCC / FGF while the other side of the coin ( present board) hasn't lived up to the "creating shareholder value" expectation.. .. think about it blockchain in the healthcare space... know which way shareholders should be voting here.....
